Following VHL inactivation, HIF2α is constitutively upregulated in sporadic and VHL-associated renal cell carcinomas, stimulating tumor growth by activating multiple downstream targets such as VEGF, PDGF, EGFR, TGFα, FGF, GLUT1, Epo, NO-synthase and cyclin D.